Nucleai
Chicago, Illinois, United States
Nucleai is committed to bringing the power of spatial biology to reality by providing pharmaceutical companies and clinicians with AI-powered image analysis applications. Nucleai's image analysis and biomarker discovery technology leverages real-world pathology, clinical and molecular datasets to better understand cancer biology, optimize patient stratification and improve patient care. Their algorithms for the analysis of pathology slides detect and characterize tissue and cell architecture, and their deep learning models drive the discovery of pathology-based spatial biomarkers.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2017
- Website
- nucleai.ai/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Nucleai?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now